Cathepsin V Mediates the Tazarotene-induced Gene 1-induced Reduction in Invasion in Colorectal Cancer Cells

Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma

(2020) Lehel Peterfi et al.   BRITISH JOURNAL OF CANCER

Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment

(2019) Eva Vidak et al.   Cells

Cathepsin B Is Upregulated and Mediates ECM Degradation in Colon Adenocarcinoma HT29 Cells Overexpressing Snail

(2019) Jakub Kryczka et al.   Cells

Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival

(2019) Sara Maimouni et al.   Oncotarget

The Ribosomal Protein RPLP0 Mediates PLAAT4-induced Cell Cycle Arrest and Cell Apoptosis

(2019) Chun-Hua Wang et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

The role of proteases in epithelial-to-mesenchymal cell transitions in cancer

(2019) Julia Mitschke et al.   CANCER AND METASTASIS REVIEWS

Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ

(2019) Michael Toss et al.   JOURNAL OF CLINICAL PATHOLOGY

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications

(2018) Niaz Mahmood et al.   Frontiers in Oncology

Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells

(2018) Sara Maimouni et al.   PLoS One

The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role

(2018) Josip Madunić   THROMBOSIS AND HAEMOSTASIS

Expression of cathepsins V and S in thymic epithelial tumors

(2017) Shizuka Kiuchi et al.   HUMAN PATHOLOGY

Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma

(2017) H. Huebner et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Expression and clinicopathological correlations of retinoid acid receptor responder protein 1 in renal cell carcinomas

(2016) Annette Zimpfer et al.   Biomarkers in Medicine

Tazarotene-Induced Gene 1 Enhanced Cervical Cell Autophagy through Transmembrane Protein 192

(2016) Rong-Yaun Shyu et al.   MOLECULES AND CELLS

TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase

(2013) X. Wang et al.   CANCER RESEARCH

Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment

(2013) MARIE MAYNADIER et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN

(2013) E E Oldridge et al.   Oncogenesis

Expression of Cysteine Protease Cathepsin L is Increased in Endometrial Cancer and Correlates With Expression of Growth Regulatory Genes

(2012) Maciej Skrzypczak et al.   CANCER INVESTIGATION

Protease-Activated Drug Development

(2012) Ki Young Choi et al.   Theranostics

Cysteine cathepsins: From structure, function and regulation to new frontiers

(2011) Vito Turk et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Tumor Suppressor RARRES1 Interacts with Cytoplasmic Carboxypeptidase AGBL2 to Regulate the α-Tubulin Tyrosination Cycle

(2011) Ziad J. Sahab et al.   CANCER RESEARCH

Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients

(2011) J. HALAMKOVA et al.   NEOPLASMA

Role of the RARRES1 gene in nasopharyngeal carcinoma

(2009) Wai Kei Kwok et al.   CANCER GENETICS AND CYTOGENETICS

Involvement of tazarotene-induced gene 1 in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells

(2009) S. Ohnishi et al.   CELL PROLIFERATION

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

(2008) László Herszényi et al.   BMC CANCER